 | Up a level |
Srivastava, Simran and Kumar, Sahil and Mishra, Suman and Rajmani, Raju S and Singh, Randhir and Dutta, Somnath and Ringe, Rajesh Prakash and Varadarajan, Raghavan (2026) Development of a thermostable and broadly neutralizing pan-sarbecovirus vaccine candidate. ACS Infect. Dis., 12 (1). pp. 104-118.
Srivastava, Simran and Kumar, Sahil and Mishra, Suman and Rajmani, Raju S and Singh, Randhir and Dutta, Somnath and Ringe, Rajesh Prakash and Varadarajan, Raghavan (2025) Development of a thermostable and broadly neutralizing pan-sarbecovirus vaccine candidate. ACS Infect. Dis., 12 (1). pp. 104-118.
Singh, Prakruti R and Dadireddy, Venkatareddy and Udupa, Shubha and Kalladi, Shashwath Malli and Shee, Somnath and Khosla, Sanjeev and Rajmani, Raju S and Singh, Amit and Ramakumar, Suryanarayanarao and Nagaraja, Valakunja (2023) The Mycobacterium tuberculosis methyltransferase Rv2067c manipulates host epigenetic programming to promote its own survival. Nat. Commun., 14 (1). p. 8497.
Khan, Mohammad Suhail and Jakob, Virginie and Singh, Randhir and Rajmani, Raju S and Kumar, Sahil and Lemonie , Celine and Kleanthous , Harry and Ringe, Rajesh P. and Dubois , Patrice M and Varadarajan, Raghavan (2023) Enhancing Immunogenicity of a Thermostable, Efficacious SARS-CoV-2 Vaccine Formulation through Oligomerization and Adjuvant Choice. Pharmaceutics, 15 (12).
Mittal, Nidhi and Kumar, Sahil and Rajmani, Raju S and Singh, Randhir and Lemoine, Virginie and Bj and Sa, Suba Soundarya and Kleanthous, Harry and Dubois, Patrice and Ringe, Rajesh P and Varadarajan, Raghavan (2023) Enhanced protective efficacy of a thermostable RBD-S2 vaccine formulation against SARS-CoV-2 and its variants. NPJ Vaccines, 8 (1). p. 161.
Kumar, Nirmal and Taily, Irshad Maajid and Singh, Charandeep and Kumar, Sahil and Rajmani, Raju S and Chakraborti, Debajyoti and Sharma, Anshul and Singh, Priyanka and Thakur, Krishan Gopal and Varadarajan, Raghavan and Ringe, Rajesh P. and Banerjee, Prabal and Banerjee, Indranil (2023) Identification of diphenylurea derivatives as novel endocytosis inhibitors that demonstrate broad-spectrum activity against SARS-CoV-2 and influenza A virus both in vitro and in vivo. Plos Pathogens , 19 (5).
Khaleeq , Sara and Sengupta, Nayanika and Kumar, Sahil and Patel, U R and Rajmani, Raju S and Reddy , Poorvi and Pandey , Suman and Singh, Randhir and Dutta, Somnath and Ringe, Rajesh P. and Varadarajan, Raghavan (2023) Neutralizing Efficacy of Encapsulin Nanoparticles against SARS-CoV2 Variants of Concern. Viruses, 15 (2).
Khatri, Bhavesh and Pramanick, Ishika and Malladi , Sameer Kumar and Rajmani, Raju S and Kumar, Sahil and Ghosh , Pritha and Sengupta, Nayanika and Rahisuddin, R and Kumar , Narender and Kumaran , S and Ringe, Rajesh P and Varadarajan, Raghavan and Dutta, Somnath and Chatterjee, Jayanta (2022) A dimeric proteomimetic prevents SARS-CoV-2 infection by dimerizing the spike protein. Nature Chemical Biology .
Ahmed, S and Khan, Mohd S and Gayathri, Savitha and Singh, Randhir and Kumar, Sahil and Patel, U R and Malladi, Sameer Kumar and Rajmani, Raju S and Vuren, P J and Riddell, Shane and Girish, Nidhi and Reddy, P and Upadhyay, A and Ringe, Rajesh P. and Raghavan, V (2021) A Stabilized, Monomeric, Receptor Binding Domain Elicits High-Titer Neutralizing Antibodies Against All SARS-CoV-2 Variants of Concern. Frontiers in immunology. ISSN 1664-3224
